undamentalytics Newsletter
Sign in

Autonomix Medical, Inc. income statement

In fiscal 2026, Autonomix Medical, Inc. reported revenue of $0 and net income of −$16.7m. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2023Mar 20232024Mar 20242025Mar 20252026Mar 2026LTMJun 2026
Revenue00000
Research and development12577
General and administrative157109
Operating income−2−12−12−17−16
Interest expense0000—
Income before tax−2−15−11−17−16
Income tax00000
Net income−2−15−11−17−16
Diluted shares (average)2m4m7m7m—
EBITDA−2−12−11−17−16

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Autonomix Medical, Inc.'s SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Autonomix Medical, Inc.